User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?

Primary tabs

download
  • Open access
  • PDF
  • 1.24 M
Vu, Hoang Phuong Thu [UCL] Ambroise, Jérôme [UCL] Dekairelle, Anne-France [UCL] Durant, Jean-François [UCL] Butoescu, Valentina Rodica [UCL] Robert, Annie [UCL] Vermylen, Christiane [UCL] Gala, Jean-Luc [UCL]
Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2014
Language Anglais
Journal information "British Journal of Clinical Pharmacology" - Vol. 79, no.3, p. 429-440 (August 2014)
Peer reviewed yes
Publisher Wiley-Blackwell Publishing Ltd. ((United Kingdom) Chichester)
issn 0306-5251
e-issn 1365-2125
Publication status Publié
Affiliations UCL - SSS/IREC/CTMA - Centre de technologies moléculaires appliquées (plate-forme technologique)
UCL - (SLuc) Service d'hématologie et d'oncologie pédiatrique
UCL - SSS/IREC/EPID - Pôle d'épidémiologie et biostatistique
Links
  1. Jemal A., Siegel R., Xu J., Ward E., Cancer Statistics, 2010, 10.3322/caac.20073
  2. Cheok Meyling H., Evans William E., Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy, 10.1038/nrc1800
  3. Kager Leo, Evans William E, Pharmacogenomics of acute lymphoblastic leukemia : , 10.1097/01.moh.0000231424.46148.f9
  4. Adam de Beaumais Tiphaine, Jacqz-Aigrain Evelyne, Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia, 10.1007/s00228-012-1251-4
  5. Evans William E., Relling Mary V., Moving towards individualized medicine with pharmacogenomics, 10.1038/nature02626
  6. Pui Ching-Hon, Robison Leslie L, Look A Thomas, Acute lymphoblastic leukaemia, 10.1016/s0140-6736(08)60457-2
  7. Stanulla Martin, Thiopurine Methyltransferase (TPMT) Genotype and Early Treatment Response to Mercaptopurine in Childhood Acute Lymphoblastic Leukemia, 10.1001/jama.293.12.1485
  8. Aplenc Richard, Thompson Jennifer, Han Peggy, La Mei, Zhao Huaqing, Lange Beverly, Rebbeck Timothy, Methylenetetrahydrofolate Reductase Polymorphisms and Therapy Response in Pediatric Acute Lymphoblastic Leukemia, 10.1158/0008-5472.can-04-2606
  9. Rocha J. C. C., Pharmacogenetics of outcome in children with acute lymphoblastic leukemia, 10.1182/blood-2004-11-4544
  10. Hou Xuwei, Wang Sili, Zhou Yuling, Xu Ziliang, Zou Yao, Zhu Xiaofan, Han Mingzhe, Pang Tianxiang, Han Zhong Chao, Cyclin D1 Gene Polymorphism and Susceptibility to Childhood Acute Lymphoblastic Leukemia in a Chinese Population, 10.1532/ijh97.a10418
  11. Bedewy, J BUON, 18, 227 (2013)
  12. Costea Irina, Moghrabi Albert, Krajinovic Maja, The influence of cyclin D1 (CCND1) 870A>G polymorphism and CCND1-thymidylate synthase (TS) gene???gene interaction on the outcome of childhood acute lymphoblastic leukaemia : , 10.1097/00008571-200309000-00006
  13. Costea, Haematologica, 91, 1113 (2006)
  14. Onay Ummiye V, Aaltonen Kirsimari, Briollais Laurent, Knight Julia A, Pabalan Noel, Kilpivaara Outi, Andrulis Irene L, Blomqvist Carl, Nevanlinna Heli, Ozcelik Hilmi, Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk, 10.1186/1471-2407-8-6
  15. Pabalan N., Bapat B., Sung L., Jarjanazi H., Francisco-Pabalan O., Ozcelik H., Cyclin D1 Pro241Pro (CCND1-G870A) Polymorphism Is Associated with Increased Cancer Risk in Human Populations: A Meta-Analysis, 10.1158/1055-9965.epi-08-0169
  16. Yang, Pediatr Blood Cancer, 54, 206 (2010)
  17. Pakakasama, Australasian J Cancer, 8, 191 (2009)
  18. Panetta, Clin Cancer Res, 8, 2423 (2002)
  19. Rhee, Mol Pharmacol, 53, 1040 (1998)
  20. Hayashi Hideki, Fujimaki Chihiro, Inoue Kazuyuki, Suzuki Toshio, Itoh Kunihiko, Genetic Polymorphism of C452T (T127I) in Human γ-Glutamyl Hydrolase in a Japanese Population, 10.1248/bpb.30.839
  21. Rots Marianne G., Pieters Rob, Peters Godefridus J., Noordhuis Paul, Van Zantwijk Christina H., Henze Gunter, Janka-Schaub Gritta E., Veerman Anjo J. P., Jansen Gerrit, Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia, 10.1046/j.1365-2141.2000.02071.x
  22. Tiseo Marcello, Giovannetti Elisa, Tibaldi Carmelo, Camerini Andrea, Di Costanzo Francesco, Barbieri Fausto, Burgers Jacobus A., Vincent Andrew, Peters Godefridus J., Smit Egbert F., Ardizzoni Andrea, Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed–carboplatin, 10.1016/j.lungcan.2012.07.009
  23. Organista-Nava Jorge, Gómez-Gómez Yazmín, Saavedra-Herrera Mónica Virginia, Rivera-Ramírez Ana Bertha, Terán-Porcayo Marco Antonio, Alarcón-Romero Luz del Carmen, Illades-Aguiar Berenice, Leyva-Vázquez Marco Antonio, Polymorphisms of the γ-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico, 10.1016/j.leukres.2009.11.027
  24. Giovannetti Elisa, Ugrasena Dewa G., Supriyadi Eddy, Vroling Laura, Azzarello Antonino, de Lange Desiree, Peters Godefridus J., Veerman Anjo J.P., Cloos Jacqueline, Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia, 10.1016/j.leukres.2007.02.011
  25. Robien K, Schubert M M, Chay T, Bigler J, Storb R, Yasui Y, Potter J D, Ulrich C M, Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation, 10.1038/sj.bmt.1705330
  26. Yang Lin, Hu Xin, Xu Luhang, Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis, 10.1007/s13277-012-0395-2
  27. Krajinovic M, Lemieux-Blanchard É, Chiasson S, Primeau M, Costea I, Moghrabi A, Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia, 10.1038/sj.tpj.6500224
  28. Lopez-Lopez E, Martin-Guerrero I, Ballesteros J, Garcia-Orad A, A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia, 10.1038/tpj.2012.44
  29. He H-R, Chen S-Y, You H-S, Hu S-S, Sun J-Y, Dong Y-L, Lu J, Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis, 10.1038/tpj.2014.10
  30. Ojha Rohit P., Gurney James G., Methylenetetrahydrofolate reductase C677T and overall survival in pediatric acute lymphoblastic leukemia: a systematic review, 10.3109/10428194.2013.792336
  31. de Jonge R., Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia, 10.1182/blood-2004-12-4941
  32. Paluku They-They, Antropo, 20, 11 (2009)
  33. Sirachainan Nongnuch, Wongruangsri Siranee, Kajanachumpol Saowanee, Pakakasama Samart, Visudtibhan Anannit, Nuchprayoon Issarang, Lusawat Apasri, Phudhicharoenrat Suchart, Shuangshoti Shanop, Hongeng Suradej, Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children, 10.1016/j.cdp.2008.02.004
  34. Radparvar Saeed, Houghton Peter J., Houghton Janet A., Characteristics of thymidylate synthase purified from a human colon adenocarcinoma, 10.1016/0003-9861(88)90458-4
  35. Krajinovic M, Costea I, Chiasson S, Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia, 10.1016/s0140-6736(02)08065-0
  36. Welsh, Clin Cancer Res, 6, 2538 (2000)
  37. Marsh Sharon, Ameyaw Margaret M., Githang'a Jessie, Indalo Anne, Ofori-Adjei David, McLeod Howard L., Novel thymidylate synthase enhancer region alleles in African populations, 10.1002/1098-1004(200012)16:6<528::aid-humu11>3.0.co;2-w
  38. Weinshilboum, Am J Hum Genet, 32, 651 (1980)
  39. McLeod Howard L., Krynetski Eugene Y., Wilimas Judith A., Evans William E., Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults : , 10.1097/00008571-199510000-00003
  40. Krynetski Eugene Y., Tai Hung-Liang, Yates Charles R., Fessing Michael Y., Loennechen Thrina, Schuetz John D., Relling Mary V., Evans William E., Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms : , 10.1097/00008571-199608000-00001
  41. Lennard L., Lilleyman J.S., Van Loon J., Weinshilboum R.M., Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia, 10.1016/0140-6736(90)91745-v
  42. Lennard L, Gibson B E, Nicole T, Lilleyman J S, Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia., 10.1136/adc.69.5.577
  43. Evans William E., Horner Michelle, Chu Ya Qin, Kalwinsky David, Roberts W. Mark, Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia, 10.1016/s0022-3476(05)83063-x
  44. Lilleyman J.S., Lennard L., Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia, 10.1016/s0140-6736(94)92400-7
  45. SZUMLANSKI CAROL, OTTERNESS DIANE, HER CHENGTAO, LEE DANIEL, BRANDRIFF BRIGITTE, KELSELL DAVID, SPURR NIGEL, LENNARD LYNNE, WIEBEN ERIC, WEINSHILBOUM RICHARD, Thiopurine Methyltransferase Pharmacogenetics: Human Gene Cloning and Characterization of a Common Polymorphism, 10.1089/dna.1996.15.17
  46. Yates Charles R., Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance, 10.7326/0003-4819-126-8-199704150-00003
  47. Otterness Diane, Szumlanski Carol, Lennard Lynne, Klemetsdal Bjørg, Aarbakke Jarle, Park-Hah Jeong Ok, Iven Heiko, Schmiegelow Kjeld, Branum Earl, O'Brien John, Weinshilboum Richard, Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*, 10.1016/s0009-9236(97)90152-1
  48. Ameyaw M., Thiopurine methyltransferase alleles in British and Ghanaian populations, 10.1093/hmg/8.2.367
  49. Tumer Tugba Boyunegmez, Ulusoy Gulen, Adali Orhan, Sahin Gurses, Gozdasoglu Sevgi, Arinç Emel, The low frequency of defectiveTPMT alleles in Turkish population: A study on pediatric patients with acute lymphoblastic leukemia, 10.1002/ajh.20947
  50. Publisher Bentham Science, Zhou Shufeng, Clinical Pharmacogenomics of Thiopurine S-methyltransferase, 10.2174/157488406784111627
  51. Sasaki Takamitsu, Goto Emi, Konno Yumiko, Hiratsuka Masahiro, Mizugaki Michinao, Three Novel Single Nucleotide Polymorphisms of the Human Thiopurine S-Methyltransferase Gene in Japanese Individuals, 10.2133/dmpk.21.332
  52. Spire-Vayron de la Moureyre Catherine, Debuysere Hervé, Mastain Bruno, Vinner Elizabeth, Marez Delphine, Lo Guidice Jean-Marc, Chevalier Dany, Brique Serge, Motte Kokou, Colombel Jean-Frédéric, Turck Dominique, Noel Christian, Flipo René-Marc, Pol Annie, Lhermitte Michel, Lafitte Jean-Jacques, Libersa Christian, Broly Franck, Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population, 10.1038/sj.bjp.0702152
  53. Adam de Beaumais Tiphaine, Fakhoury May, Medard Yves, Azougagh Said, Zhang Daolun, Yakouben Karima, Jacqz-Aigrain Evelyne, Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy : Mercaptopurine pharmacokinetics and hepatotoxicity, 10.1111/j.1365-2125.2010.03867.x
  54. Stocco G, Cheok MH, Crews KR, Dervieux T, French D, Pei D, Yang W, Cheng C, Pui C-H, Relling MV, Evans WE, Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia, 10.1038/clpt.2008.154
  55. Stocco Gabriele, Crews Kristine R, Evans William E, Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status, 10.1517/14740330903426151
  56. Marsh S, Van Booven DJ, The Increasing Complexity of Mercaptopurine Pharmacogenomics, 10.1038/clpt.2008.219
  57. Kim Hyery, Kang Hyoung Jin, Kim Hyo Jeong, Jang Mi Kyung, Kim Nam Hee, Oh Yongtaek, Han Byoung-Don, Choi Ji-Yeob, Kim Chul Woo, Lee Ji Won, Park Kyung Duk, Shin Hee Young, Ahn Hyo Seop, Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism, 10.1371/journal.pone.0045558
  58. Farfan Mauricio J, Salas Carolina, Canales Cristina, Silva Felipe, Villarroel Milena, Kopp Katherine, Torres Juan P, Santolaya María E, Morales Jorge, Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia, 10.1186/1471-2407-14-299
  59. Vu Hoang, J Pediatr Hematol Oncol (2013)
  60. Louis Magali, Dekairelle Anne France, Gala Jean-Luc, Rapid combined genotyping of factor V, prothrombin and methylenetetrahydrofolate reductase single nucleotide polymorphisms using minor groove binding DNA oligonucleotides (MGB probes) and real-time polymerase chain reaction, 10.1515/cclm.2004.255
  61. Dewit O., Moreels T., Baert F., Peeters H., Reenaers C., de Vos M., Van Hootegem Ph., Muls V., Veereman G., Mana F., Van Outryve M., Holvoet J., Naegels S., Piessevaux H., Horsmans Y., Gala J.L., Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients, 10.1016/j.clinbiochem.2011.06.079
  62. Vittinghoff Eric, Glidden David V., Shiboski Stephen C., McCulloch Charles E., Regression Methods in Biostatistics, ISBN:9781461413523, 10.1007/978-1-4614-1353-0
  63. Heagerty Patrick J., Lumley Thomas, Pepe Margaret S., Time-Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker, 10.1111/j.0006-341x.2000.00337.x
  64. R Development Core Team R: a language and environment for statistical computing 2005 http://www.R-project.org
  65. Chen Xiaowen, Wen Feiqiu, Yue Lijie, Li Changgang, Genetic Polymorphism of γ-Glutamyl Hydrolase in Chinese Acute Leukemia Children and Identification of a Novel Double Nonsynonymous Mutation, 10.3109/08880018.2012.657767
  66. Lauten, Haematologica, 88, 353 (2003)
  67. Lu Y Kham YKS Hany A Tan AM Quah TC Juh Yeoh AE Host pharmacogenetic factors significantly contribute to refinement of prognosis in children with Acute Lymphoblastic Leukemia (ALL): result from the Malaysia-Singapore (Ma-Spore) ALL 2003 Study ASH 2011
Bibliographic reference Vu, Hoang Phuong Thu ; Ambroise, Jérôme ; Dekairelle, Anne-France ; Durant, Jean-François ; Butoescu, Valentina Rodica ; et. al. Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?. In: British Journal of Clinical Pharmacology, Vol. 79, no.3, p. 429-440 (August 2014)
Permanent URL http://hdl.handle.net/2078.1/187702